RiboNova Inc.
Wynnewood
About RiboNova Inc.
RiboNova is a biopharmaceutical company in the Lankenau Institute for Medical Research near Philadelphia. The company is developing novel therapies for the treatment of serious rare diseases, including mitochondrial disease and certain cancers. RiboNova's drug discovery platform is targeting transfer RNA molecules.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $25.0K
- Last round: Series Unknown (Mar 2019)
- Website: ribonova.com
- Phone: (610) 801-2541
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ribonova-inc-198243 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.